News
The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...
1d
India Today on MSNMicrosoft nabs 24 DeepMind AI experts, Amar Subramanya is new AI VPMicrosoft has hired 24 former DeepMind employees, including Amar Subramanya as its new AI VP, in a major move to strengthen ...
20h
Tech Xplore on MSNAI meets antiquity: Ancient historian tests DeepMind's transformative new modelA University of Warwick epigraphy expert has collaborated with Google DeepMind to evaluate "Aeneas," an AI model that ...
7d
Zacks.com on MSNGoogle Goes Windsurfing in the AI War for TalentThe "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...
Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation. President Colin Murdoch revealed the company's ...
1d
New Scientist on MSNDeepMind and OpenAI claim gold in International Mathematical OlympiadTwo AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...
17d
GlobalData on MSNIsomorphic Labs prepares to launch trials for AI-designed drugsAlphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results